Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis - Abdul-Aziz, M H; Sulaiman, H; Mat-Nor, M B (Intensive Care Med, 2016)
et al.